Skip to content

USANA Health Sciences USNA Contract Liabilities

Contract Liabilities at other companies

Celsius Holdings, Inc. logo
Celsius Holdings, Inc.CELH
$395.28M+154%

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$363.35M-36.1%
P/E18.1×+7.8×
P/S0.4×-0.3×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0.0×
Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's contract liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's contract liabilities?
USANA Health Sciences (USNA) reported contract liabilities of $10.32M in Q1 2026.
How has USANA Health Sciences's contract liabilities changed year-over-year?
USANA Health Sciences's contract liabilities decreased by 14.6% year-over-year, from $12.09M to $10.32M.
What is the long-term trend for USANA Health Sciences's contract liabilities?
Over 5 years (2020 to 2025), USANA Health Sciences's contract liabilities has grown at a -7.8% compound annual growth rate (CAGR), from $15.95M to $10.64M.
What does contract liabilities mean?
Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.